Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Ernexa Therapeutics Inc (NASDAQ: ERNA) closed at $0.23 in the last session, down -0.43% from day before closing price of $0.23. In other words, the price has decreased by -$0.43 from its previous closing price. On the day, 0.79 million shares were traded.
Ratios:
We take a closer look at ERNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.21.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Cherington Charles bought 3,768,397 shares for $0.10 per share. The transaction valued at 394,174 led to the insider holds 20,401,602 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 26.44.
Stock Price History:
Over the past 52 weeks, ERNA has reached a high of $2.62, while it has fallen to a 52-week low of $0.15. The 50-Day Moving Average of the stock is 8.15%, while the 200-Day Moving Average is calculated to be -64.59%.
Shares Statistics:
A total of 52.25M shares are outstanding, with a floating share count of 24.27M. Insiders hold about 61.08% of the company’s shares, while institutions hold 2.39% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
